Greg Mattingly, a child psychiatrist who teaches pharmacology at the Washington University School of Medicine. “It’s simply another delivery mechanism for a medication that already exists and has widespread use.”Īnd for kids who balk at swallowing pills, Adzenys could be a boon, said Dr. “There’s nothing revolutionary about this drug,” Biermann said. ![]() Ben Biermann, an assistant professor of psychiatry at University of Michigan’s C.S. Those who abuse the drug won’t care if it comes in the form of a nice-tasting chewable or a traditional pill: They’re only focused on the effects of the drug, said Dr. Some psychiatrists see no reason to worry about Adzenys. “Why would that be the case if there wasn’t a need for this?” A convenience for harried moms - or for dealers? Adzenys XR-ODT extended-release tablets NEOS “You go to a pharmacy, and everything is in gummy bear format,” Garg said. He sees the dissolving tabs as part of a broader trend to making medications and supplements of all types more pleasant to take. It could also be useful for the adult ADHD population, he said: If they forget to take their pill with breakfast, they could just pop a tablet on the way to work. Garg says the new, quick-dissolving formulation will help harried mothers get their kids medicated faster before school. It’s also the first to come in a blister pack, not a pill bottle - making it exceptionally portable and convenient. Sales for ADHD medications were at $4.7 billion in 2006, had nearly tripled to $12.7 billion by last year, and are projected to grow to $17.5 billion by 2020, according to a 2015 report from market research firm IBISWorld.įDA moves to ban use of electric shock devices to treat childrenĪdzenys is the first extended-release drug for ADHD that dissolves in the mouth (though a rival drug, Shire’s Vyvanse, comes in capsules that can be opened so the medication can be sprinkled over food). In teens and adults, there’s also rampant misuse: These stimulants are commonly used as party drugs and as performance enhancement aids some students say the meds help them focus and improve their grades.Īll that adds up to a booming market. (The Centers for Disease Control and Prevention advises parents to try behavior therapy before pharmaceutical intervention.) But the line between need and want is increasingly blurry.Ībout 75 percent of children diagnosed with ADHD are on medication - a statistic that concerns many psychiatrists. ![]() ![]() There’s a very real population of children and adults whose lives are vastly improved by medications like Adderall and Ritalin, which stimulate the central nervous system and affect chemicals in the brain associated with impulse control. And analysts are generally bullish about Neos’s prospects. The product is winning support from doctors who see it as a convenient way to give children the drugs they need. The company has 125 sales reps across the United States, and they’re having “no problem” getting appointments with doctors interested in prescribing this new formulation, Garg said. The Dallas company behind the drug, Neos Therapeutics, began ramping up commercial efforts this week in order to get “ahead of back-to-school season,” CEO Vipin Garg said. Exclusive analysis of biotech, pharma, and the life sciences Learn Moreĭo antidepressants during pregnancy increase baby’s autism risk?Īdzenys, an extended-release amphetamine, was approved by the Food and Drug Administration in January for patients 6 years and older.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |